Tilray Inc (NASDAQ:TLRY - Get Free Report) shares rose 3.3% on Monday . The stock traded as high as $1.76 and last traded at $1.75. Approximately 8,369,267 shares were traded during trading, a decline of 67% from the average daily volume of 25,055,100 shares. The stock had previously closed at $1.69.
Wall Street Analysts Forecast Growth
Separately, Roth Mkm cut their price objective on shares of Tilray from $2.00 to $1.75 and set a "neutral" rating for the company in a research report on Friday, October 11th.
Read Our Latest Report on TLRY
Tilray Trading Up 2.4 %
The stock has a market cap of $1.34 billion, a PE ratio of -3.93 and a beta of 2.13. The company has a current ratio of 2.47, a quick ratio of 1.57 and a debt-to-equity ratio of 0.08. The firm has a fifty day simple moving average of $1.71 and a two-hundred day simple moving average of $1.79.
Tilray (NASDAQ:TLRY - Get Free Report) last announced its earnings results on Thursday, October 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.04). The business had revenue of $200.00 million during the quarter, compared to analyst estimates of $218.70 million. Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. Tilray's revenue for the quarter was up 13.0% on a year-over-year basis. During the same period in the previous year, the business posted ($0.10) earnings per share. As a group, equities analysts expect that Tilray Inc will post -0.14 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Prospect Financial Services LLC bought a new stake in Tilray in the 2nd quarter worth approximately $26,000. Signature Estate & Investment Advisors LLC bought a new stake in shares of Tilray in the 2nd quarter worth approximately $29,000. Jeppson Wealth Management LLC purchased a new stake in shares of Tilray in the 2nd quarter valued at $33,000. Vanguard Capital Wealth Advisors bought a new position in shares of Tilray during the 2nd quarter valued at $34,000. Finally, HBK Sorce Advisory LLC purchased a new position in Tilray in the 1st quarter worth $37,000. 9.35% of the stock is currently owned by hedge funds and other institutional investors.
About Tilray
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Featured Articles
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
